The aim is to show our evolution for reconstruction of long bones in the child with free vascularized fibula after tumoral resection. Between 1990 and 2004, 78 children were operated on for sarcoma of long bones and one girl with congenital pseudarthrosis. The main applications are illustrated: U-shaped fibular transplant, fibular epiphysis with growth plate and diaphysis transfer, fibular graft associated to massive allograft. Follow-up of the children was performed by clinical examination and standard X-ray. No post operative death occurred. Many benign complications for femoral reconstruction were observed. So our recent evolution is to use vascularized fibula associated with massive allograft; but resorption of allograft was observed 3 years later. Vascularized fibula for reconstruction of long bones is the ideal material. The result is definitive. The future for femur is perhaps vascularized fibula associated with osseous substitute.
We describe a retrospective review of 38 cases of reconstruction following resection of the metaphysiodiaphysis of the lower limb for malignant bone tumours using free vascularised fibular grafts. The mean follow-up was for 7.6 years (0.4 to 18.4). The mean Musculoskeletal Tumor Society score was 27.2 (20 to 30). The score was significantly higher when the graft was carried out in a one-stage procedure after resection of the tumour rather than in two stages. Bony union was achieved in 89% of the cases. The overall mean time to union was 1.7 years (0.2 to 10.3). Free vascularised fibular transfer is a major operation with frequent, but preventable, complications which allows salvage of the limb with satisfactory functional results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.